Geographic atrophy is an advanced form of dry age-related macular degeneration that causes vision loss in older adults. Until recently, there were no treatments available to target the root cause.

During the past few years, there have been tremendous advances in the treatment of several significant eye diseases ... Occasionally, surgery is performed to release the pressure on the optic nerve.

Your optic nerve is important as it is essential to our sight. The optic nerve’s function is to transmit information that we see and what is formed on our retina (situated at the back of your ...

In an interview with Ophthalmology Times, Quan Dong Nugyen, MD, MSc, discusses ongoing research into Tinlarebant, an ...

Local estrogen therapy is the treatment of choice for women with vulvovaginal atrophy who lack other postmenopausal symptoms. Systemic estrogen therapy is indicated for vulvovaginal atrophy only ...

Learn more about about the gadgets and habits that some people with color deficiency use to live with it and to explore the prospects of various treatments.

Deficiencies due to malabsorption: if severe, may need to treat like pernicious anemia; use oral preparations for chronic treatment. Schilling test: 1000mcg. Hereditary optic nerve atrophy (Leber ...

Multiple sclerosis (MS) is a disease of the central nervous system that causes damage to your brain, spinal cord, and optic ... atrophy may begin even before an MS diagnosis. When nerve fibers ...

The microvascular changes in the anterior optic nerve in human glaucomatous eyes were examined by selective methylmethacrylate microvascular corrosion castings following cannulation of the central ...

Optic atrophy is a condition in which the optic nerve, which carries images of what the eye sees ... Normally, this syndrome is treatable and can be treated by conferring treatment techniques of ...

Again, the signs and symptoms of secondary syphilis resolve spontaneously without treatment ... system involvement (mental retardation, optic nerve atrophy, seizure disorders), and bone or ...

Generated $196.8 million in 3Q 2024 revenues, including $176.6 million in U.S. net product salesGrew SYFOVRE® (pegcetacoplan injection) demand by ...